NasdaqCM - Nasdaq Real Time Price USD
Lexaria Bioscience Corp. (LEXX)
1.5532
-0.0368
(-2.31%)
As of 11:59:35 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 91.33k | 91.33k | 458k | 523k |
| Low Estimate | -- | -- | 184k | -- |
| High Estimate | 174k | 174k | 706k | 1.17M |
| Year Ago Sales | 84k | 84k | 464.28k | 458k |
| Sales Growth (year/est) | 8.73% | 8.73% | -1.35% | 14.19% |
Earnings History
| Currency in USD | 5/31/2024 | 8/31/2024 | 11/30/2024 | 2/28/2025 |
|---|---|---|---|---|
| EPS Est. | -0.09 | -0.11 | -0.12 | -0.16 |
| EPS Actual | -0.13 | -0.15 | -0.16 | -0.15 |
| Difference | -0.04 | -0.04 | -0.04 | 0.01 |
| Surprise % | -39.29% | -32.36% | -33.33% | 8.16% |
EPS Trend
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (May 2025) | Next Qtr. (Aug 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LEXX | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/24/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/2/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/18/2024 |
| Initiated | HC Wainwright & Co.: Buy | 7/10/2024 |
| Maintains | Maxim Group: Buy to Buy | 3/5/2024 |
Related Tickers
BCTXW BriaCell Therapeutics Corp.
0.1899
+57.38%
LIXT Lixte Biotechnology Holdings, Inc.
1.2800
-2.29%
RNTX Rein Therapeutics Inc.
1.7500
-3.85%
IPHA Innate Pharma S.A.
1.9700
0.00%
LTRN Lantern Pharma Inc.
3.6500
-2.14%
INTS Intensity Therapeutics, Inc.
0.9900
-23.85%
KAPA Kairos Pharma, Ltd.
0.8446
-1.80%
TRAW Traws Pharma, Inc.
1.5200
+3.40%
SPRB Spruce Biosciences, Inc.
0.1325
-0.30%
UBX Unity Biotechnology, Inc.
0.9995
+1.37%